This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Bavarian Nordic A/s. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: Karen Baur: Innovator in Recombinant Virus Technology
Introduction
Karen Baur is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant viruses. With a total of 3 patents to her name, her work focuses on innovative solutions for medical applications.
Latest Patents
One of her latest patents is titled "Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elements." This invention relates to a replication deficient recombinant virus that encodes at least one antigen and/or antigenic epitope. The expression of this antigen is regulated by a transcriptional control element that comprises at least two elements driving early expression. This technology has potential applications as a medicament or vaccine.
Career Highlights
Karen Baur is currently employed at Bavarian Nordic A/S, where she continues to advance her research in recombinant virus technology. Her innovative work has positioned her as a key figure in the biotechnology sector.
Collaborations
Throughout her career, Karen has collaborated with notable colleagues, including Jürgen Hausmann and Kay Brinkmann. These partnerships have further enhanced her research and development efforts.
Conclusion
Karen Baur is a trailblazer in the field of recombinant virus technology, with her patents paving the way for future medical advancements. Her contributions are invaluable to the ongoing evolution of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile